Monopar Therapeutics has evolved from early radiopharma assets into a more concrete bet with ALXN1840 for rare diseases. Click for this MNPR stock update.
Werd I/O on MSNOpinion
Notable links: July 3, 2026
AI, surveillance, open tech, and news as a business.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results